ArticleAllergy, asthma & immunology research2011
Current control and future risk in asthma management.
Article in Allergy, asthma & immunology research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 63 citations in OpenAlex.
- Impact of comorbid asthma on severity of coronavirus disease (COVID-19).Scientific reports · 2020Trial
- Trial
- Time to Rethink ICS Dosing in Pursuit of Asthma Clinical Remission: High-Dose ICS/LABA May Restore Short-Term Asthma Control When Medium Doses Fail.Journal of clinical medicine · 2026Article
- Article
- COVID-19 Vaccination Prioritization Strategies in Malaysia: A Retrospective Analysis of Early Evidence.Vaccines · 2022Review
- A model to predict a risk of allergic rhinitis based on mitochondrial DNA copy number.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022Article
- Article
- Risk of asthma exacerbation associated with opioid and nonopioid analgesic use in children with current asthma.Journal of managed care & specialty pharmacy · 2022Article
- An Investigation on the Consciousness of Patients and Pharmacists Regarding Inhaler Education.The Kobe journal of medical sciences · 2021Article
- Development and equivalence of new faces for inclusion in the Childhood Asthma Control Test (C-ACT) response scale.Journal of patient-reported outcomes · 2021Article
- Small airway dysfunction and poor asthma control: a dangerous liaison.Clinical and molecular allergy : CMA · 2021Review
- High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma.Journal of asthma and allergy · 2021Article
- A Questionnaire Survey of the Inhalation Instruction in Pharmacies.The Kobe journal of medical sciences · 2020Article
- A multinational observational study identifying primary care patients at risk of overestimation of asthma control.NPJ primary care respiratory medicine · 2019Observational
- Understanding reliever overuse in patients purchasing over-the-counter short-acting betaBMJ open · 2019Observational
- Recent Advances in Inflammation and Treatment of Small Airways in Asthma.International journal of molecular sciences · 2019Review
- Identifying Asthma Exacerbation-Related Emergency Department Visit Using Electronic Medical Record and Claims Data.Applied clinical informatics · 2018Article
- Living with asthma and chronic obstructive airways disease: Using technology to support self-management - An overview.Chronic respiratory disease · 2017Review
- The evidence on tiotropium bromide in asthma: from the rationale to the bedside.Multidisciplinary respiratory medicine · 2017Review
- Criterion validity of 8-item Morisky Medication Adherence Scale in patients with asthma.PloS one · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite international and national guidelines, poor asthma control remains an issue. Asthma exacerbations are costly to both the individual, and the healthcare provider. Improvements in our understanding of the therapeutic benefit of asthma therapies suggest that, in general, while long-acting bronchodilator therapy improves asthma symptoms, the anti-inflammatory activity of inhaled corticosteroids reduces acute asthma exacerbations. Studies have explored factors which could be predictive of exacerbations. A history of previous exacerbations, poor asthma control, poor inhaler technique, a history of lower respiratory tract infections, poor adherence to medication, the presence of allergic rhinitis, gastro-oesophageal reflux disease, psychological dysfunction, smoking and obesity have all been implicated as having a predictive role in the future risk of asthma exacerbation. Here we review the current literature and discuss this in the context of primary care management of asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.